Treatment options for advanced breast cancer rely on chemotherapy, targeted therapy (e.g. HER2-directed therapy, Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitors, antibody-drug conjugates), endocrine therapy, immunotherapy, or combinations of these therapies [4, 5]. Here, ERBB2 is linked to breast carcinoma.